Sigma Healthcare (ASX:SIG) said its Chemist Warehouse unit reported preliminary unaudited total retail network sales of AU$5.15 billion in the fiscal half ended December 2024, compared with AU$4.56 billion a year earlier, according to a Tuesday filing with the Australian bourse.
The pharmacy's preliminary unaudited total like-for-like retail network sales grew 10.3% compared with an 8.9% growth the previous year, driven by a strong trading performance in December 2024, the filing said.
Shares of Sigma Healthcare rose 8% in recent Tuesday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。